Across TCGA pan-cancer cohorts, VENTXP8 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of VENTXP8’s most consistent transcriptional readouts.
The strongest signal is observed in breast invasive carcinoma (BRCA), where VENTXP8 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types VENTXP8 is over-expressed in tumor.
BRCA are the cancer types where VENTXP8 tumor–normal differential expression is most reproducible.